(Reuters) -Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) for its starting dose of 2.5 mg in India, stepping ...

Mounjaro and Zepbound are two brand-name glucagon-like peptide-1 (GLP-1) medications manufactured by Eli Lilly. Although they ...

The “golden dose” left in Mounjaro or Ozempic pens may do more harm than good, according to experts. Design by MNT; Photography by Bloomberg/Getty Images As of 2024, researchers estimated that about ...

Although Mounjaro is not FDA-approved for weight loss, it contains the same active ingredient as Zepbound (tirzepatide), ...

It looks like the weight-loss injection craze isn’t going away any time soon. From today, it’s become legal for GPs to prescribe the Mounjaro jab to users, adding to the estimated 500,000 people who ...

Add Yahoo as a preferred source to see more of our stories on Google. A patient holds a Mounjaro injectible pen. (Sandy Huffaker / Washington Post / Getty Images) In the first head-to-head comparison ...

When James Norris, a 56-year-old mechanic from Roxbury, New Jersey, went on a low dose of Mounjaro, a GLP-1 medication similar to Ozempic, to lose weight in March 2023, he thought it would be a ...

Eli Lilly and Company (NYSE:LLY) is one of the best stocks to invest in for long-term growth. Eli Lilly and Company (NYSE:LLY) launched the easy-to-use injector pen of its weight-loss and diabetes ...

Drinking alcohol while using Mounjaro is generally considered safe, but it may increase the likelihood of the drug’s side effects. Alcohol can also make blood sugar levels harder to manage for people ...